Economic Benefits of Surgical Aortic Valve Replacement on Patients With Symptomatic Aortic Valve Regurgitation
SAVR performed within 12 months of an sAR diagnosis is associated with improved mortality and lower annualized health care use and costs. These clinical and economic benefits should be considered when managing patients with sAR.
Authors
- Natalie Heidrich
- Candace Gunnarsson (ORCID: https://orcid.org/0000-0003-0723-585X)
- Sasha Still (ORCID: https://orcid.org/0000-0002-1434-7123)
- Michael P. Ryan (ORCID: https://orcid.org/0000-0002-7207-7926)
- James E. Davies (ORCID: https://orcid.org/0000-0003-2400-4025)
Institutions
- University of Alabama at Birmingham (US)
- Edwards Lifesciences (United States) (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1161/jaha.124.035278
- Citations
- 2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.80